Protein
Protein targets on GLP-1: a starting framework
What the obesity-medicine and clinical-nutrition literature suggests as starting protein-target ranges for adults under hypocaloric conditions on GLP-1 receptor agonist therapy. Hedged, individualizable, and not a substitute for clinician guidance.
The single most-asked nutrition question from patients on GLP-1 receptor agonist therapy is how much protein they should be eating. This article is the keystone reference for the protein-target framework used elsewhere on this site.
Why protein matters specifically on GLP-1
Body-composition substudies of the STEP and SURMOUNT trials and of related real-world cohorts consistently report that an estimated 25-40% of total weight lost on GLP-1 receptor agonists is lean tissue. This is consistent with what is observed in non-pharmacologic rapid weight loss but is now occurring at population scale.
Two modifiable inputs are consistently cited in the obesity-medicine and clinical-nutrition literature for preserving lean mass under rapid weight loss:
- Adequate protein intake.
- Resistance training (covered in detail in the muscle-mass section).
This article addresses the first.
Starting protein-target ranges
The following are starting ranges discussed in the obesity-medicine, clinical-nutrition, and exercise-science literature for adults under hypocaloric conditions. They are starting points for individualization with a clinician or dietitian. They are not prescriptions, and they are not appropriate for every patient.
Adults >65 years, hypocaloric, on GLP-1, normal renal function: approximately 1.4-1.8 g protein per kg of lean body mass per day.
Adults with chronic kidney disease: individualized only — defer entirely to nephrology team.
Adults engaged in regular resistance training: typically the upper end of the cited range, with attention to per-meal pacing.
Why “per kg lean body mass” rather than “per kg total body weight”
Recommendations expressed per kg of total body weight tend to under-target patients with higher body-fat percentages and over-target patients with lower body-fat percentages. Per-kg-LBM expression is more physiologically meaningful for protein adequacy in the context of body-composition concerns.
In practice, lean body mass can be estimated several ways: from a recent DXA scan, from a clinical bioelectrical impedance reading, or from a published estimating equation. Estimates carry their own error; precision in lean-body-mass measurement is not the limiting factor in most patients’ protein adequacy.
Worked example
A 90 kg adult with an estimated lean body mass of 60 kg, hypocaloric, on Wegovy, with normal renal function:
- Lower end of starting range: 1.2 × 60 = 72 g protein per day.
- Upper end of starting range: 1.6 × 60 = 96 g protein per day.
A reasonable starting daily target for this patient, in conversation with their dietitian, might be approximately 80-95 g protein per day, distributed across 4-5 eating occasions.
Caveats and considerations
Renal disease
Patients with chronic kidney disease (CKD) have individualized protein requirements that may be substantially below the ranges cited above. The framework here does not apply to CKD; defer entirely to your nephrology team.
Older adults
The literature on protein adequacy in older adults — including the PROT-AGE study group recommendations (Bauer et al. 2013) — supports higher protein targets in adults over 65 because of the higher baseline sarcopenia risk. The 1.4-1.8 g/kg LBM range cited above reflects this.
Per-meal pacing
Total daily protein intake matters, but distribution across meals also matters. Muscle protein synthesis is stimulated by per-meal protein intake reaching a leucine threshold of approximately 2.5-3 g leucine per meal — corresponding to roughly 25-30 g of high-quality animal protein or 35-45 g of plant protein. The protein-pacing article on this site covers this in detail.
Quality
Animal proteins (whey, casein, eggs, fish, poultry, lean meat) are generally complete and reach the leucine threshold at smaller per-meal portions than plant proteins. Plant proteins can absolutely meet protein needs but typically require larger per-meal portions or strategic combination. The whey-vs-plant-protein article covers this.
Why not just eat more?
On GLP-1 therapy, “just eat more protein” is not the practical instruction it would be off therapy. Appetite is suppressed, gastric emptying is slowed, and meal capacity is smaller. Strategic placement of protein at the front of meals, smaller more frequent eating occasions, and consideration of protein-dense liquid options (Greek yogurt, protein shakes) are how patients hit the target in practice.
How to track
The simplest way to track progress against a protein target is in any of the calorie/macro tracker apps. Apps that surface per-meal protein and per-day protein against a personal target reduce the cognitive load (PlateLens, MyNetDiary GLP-1, Cronometer, MacroFactor are all reasonable choices; see the app reviews).
Patients who do not want to use a tracker can estimate from a brief written meal log over 3-5 days, reviewed with their dietitian. A 7-day audit is often more clinically useful than continuous tracking.
What “not enough protein” actually looks like
The clinical signs of inadequate protein intake under rapid weight loss include disproportionate lean-mass loss (visible on DXA or bioelectrical impedance over months), reduced strength under standardized resistance-training measurements, and (in older adults) accelerated functional decline. None of these are visible from a single day of food log; they are detected over months in clinical follow-up.
Common questions
“Is more protein always better?” No. Above the starting ranges cited, additional protein has diminishing benefit and may increase total caloric intake, displace other nutrients, or stress renal function in patients with subclinical CKD. The starting ranges are starting ranges; individualization is the goal.
“Can I meet my protein target with shakes only?” Many patients do for some meals or some days, particularly in active dose escalation when whole-food meals are difficult. Shakes are a valid tool. They do not need to be the only tool.
“Should I worry if I miss the target on a single day?” No. The relevant measurement is the running 7-14-day average, not any single day. The pattern matters more than any individual day.
References
- Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association. 2013;14(8):542-559.
- Phillips SM, Chevalier S, Leidy HJ. Protein “requirements” beyond the RDA: implications for optimizing health. Applied Physiology, Nutrition, and Metabolism. 2016;41(5):565-572.
- Holmstrup ME, Fairman CM, Calanna S, et al. Body composition during pharmacologic weight loss with GLP-1 receptor agonists: implications for protein adequacy and resistance training. Obesity Reviews. 2025;26(4):e13721.
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine. 2022;387(3):205-216.
- Cava E, Yeat NC, Mittendorfer B. Preserving healthy muscle during weight loss. Advances in Nutrition. 2017;8(3):511-519.